Tempus, a medical data and diagnostics startup founded by Eric Lefkofsky of Groupon fame, has announced that it’s raised $200 million in fresh equity funding that values it at $8.1 billion post-money. Tempus also closed a $250 million debt round along with the new equity round and has now raised a total of $1.05 billion in equity and debt funding since it was founded.

The $200 million round was an extension of a $100 million Series G round that Tempus closed this year in March. It came from a group of investors including Google, Baillie Gifford, Franklin Templeton, T. Rowe Price, and the company’s founder Eric Lefkofsky, who previously made a name for himself as the co-founder and former CEO of the group-buying site Groupon.

With the new funding, Tempus says it’ll expand its operations, venturing away from its focus on cancer into other areas such as infectious diseases, cardiology, and mental health problems like depression. Tempus has created one of the largest repositories of healthcare data that it offers as a service to healthcare companies. With its data, it helps to facilitate the development of drugs and treatments for certain ailments, with a major focus on cancer.

Chicago-based Tempus was founded in 2015 and has grown to now employ over 1,500 people. With a valuation of $8.1 billion from its new round, it makes a mark as the most valuable startup in the Chicago area and the state of Illinois at large.

Photo: Tempus CEO Eric Lefkofsky by Fortunebrainstormhealth is licensed under CC BY-NC-ND 2.0

Share this...

Facebook

Pinterest

Twitter

Linkedin

Whatsapp

Email

Print